SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences informs about closure of trading window

30 Sep 2022 Evaluate

Suven Life Sciences has informed that the ‘Trading Window’ for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st October, 2022 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending 30th September, 2022, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

264.05 -4.10 (-1.53%)
22-Jun-2026 10:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.70
Dr. Reddys Lab 1279.15
Cipla 1401.50
Zydus Lifesciences 1067.60
Lupin 2351.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: